DSC3 and breast carcinoma: Recent studies have observed loss of DSC3 in several cancer types, such as lymph node metastases of oral squamous cell carcinoma, breast cancer and colorectal cancer, where the decreased levels associated with cancer progression were regulated by epigenetic modification[13], [14], [15].